Skip to Main Content

Author Details

Frederic G Barr
Center for Cancer Research
1985
155
59
PMIDPaper TitleJournal TitlePublished Year
36322002The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.Clin Cancer Res2023
36322002The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.Clin Cancer Res2023
35158790NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma.Cancers (Basel)2022
35452896Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.Eur J Cancer2022
35441778Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.Am J Med Genet A2022
35861986Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.Eur J Endocrinol2022
37146302Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.Proc Natl Acad Sci U S A2022
35158790NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma.Cancers (Basel)2022
35441778Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.Am J Med Genet A2022
35861986Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.Eur J Endocrinol2022
35452896Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.Eur J Cancer2022
37146302Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.Proc Natl Acad Sci U S A2022
34166228Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.J Clin Invest2021
33913590MYOD1 as a prognostic indicator in rhabdomyosarcoma.Pediatr Blood Cancer2021
33589519A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.Cancer Res2021
34166228Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.J Clin Invest2021
34976830Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.Front Oncol2021
34386729Evidence of pioneer factor activity of an oncogenic fusion transcription factor.iScience2021
33589519A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.Cancer Res2021
33913590MYOD1 as a prognostic indicator in rhabdomyosarcoma.Pediatr Blood Cancer2021
34976830Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.Front Oncol2021
34386729Evidence of pioneer factor activity of an oncogenic fusion transcription factor.iScience2021
32934208Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity.Nat Commun2020
32934208Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity.Nat Commun2020
30617281Rhabdomyosarcoma.Nat Rev Dis Primers2019
30565669Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.Int J Cancer2019
30617281Rhabdomyosarcoma.Nat Rev Dis Primers2019
31456361Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.Cancer Med2019
31456361Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.Cancer Med2019
30565669Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.Int J Cancer2019
29730428The expression and function of PAX3 in development and disease.Gene2018
30459282The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.Sci Signal2018
30373318Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.Molecules2018
29730428The expression and function of PAX3 in development and disease.Gene2018
30459282The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.Sci Signal2018
30373318Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.Molecules2018
28058850Molecular diagnostics in the management of rhabdomyosarcoma.Expert Rev Mol Diagn2017
28446439PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.Cancer Discov2017
28521080Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Pediatr Blood Cancer2017
28058850Molecular diagnostics in the management of rhabdomyosarcoma.Expert Rev Mol Diagn2017
28138962PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.J Pathol2017
28138962PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.J Pathol2017
28446439PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.Cancer Discov2017
28521080Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Pediatr Blood Cancer2017
26756883Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.Pediatr Blood Cancer2016
26756883Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.Pediatr Blood Cancer2016
26983595Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications.Int J Oncol2016
27799565Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.Proc Natl Acad Sci U S A2016
27550633Fusion genes in solid tumors: the possibilities and the pitfalls.Expert Rev Mol Diagn2016
27799565Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.Proc Natl Acad Sci U S A2016
  • 1 - 50 of 310

Recommended Authors

Yun-Shao Sung
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 4
Delphine Guillemot
Institut Curie Hospital
Career Start Year 2010
Number of shared co-authors 5
Dina Halai
Royal National Orthopaedic Hospital National Health Service Trust
Career Start Year 2010
Number of shared co-authors 7
Lei Zhang
Guangzhou Kingmed Center for Clinical Laboratory
Career Start Year 2009
Number of shared co-authors 5
Thomas G P Gr??newald
German Cancer Research Center
Career Start Year 2006
Number of shared co-authors 16
Ken Kikuchi
Kyoto Prefectural University of Medicine
Career Start Year 2002
Number of shared co-authors 18
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 7
Noah Federman
University of California los angeles
Career Start Year 2001
Number of shared co-authors 6
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Career Start Year 2001
Number of shared co-authors 5
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 4
Andre M Oliveira
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 5
Piergiorgio Modena
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 2
Karoly Szuhai
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 13
Franck Tirode
Cancer Center of Lyon
Career Start Year 1997
Number of shared co-authors 17
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 14
Jane Bayani
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 2
Gudrun Schleiermacher
Institut Curie
Career Start Year 1994
Number of shared co-authors 9
Nalan Gokgoz
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1993
Number of shared co-authors 11
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 3
Mary Shago
The Hospital for Sick Children, University of Toronto
Career Start Year 1990
Number of shared co-authors 5
Jeremy Clark
Norwich Medical School, University of East Anglia
Career Start Year 1989
Number of shared co-authors 2
Choh Yeung
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 9
Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Career Start Year 1986
Number of shared co-authors 22
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 15
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 6
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 9
Jeremy A Squire
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 4
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 18
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1978
Number of shared co-authors 15
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 9

Collaborators

David M Parham
Keck School of Medicine, University of Southern California
Co-authored papers 14
Douglas S Hawkins
Co-authored papers 13
Jaclyn A Biegel
Co-authored papers 10
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers 10
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 9
Richard B Womer
Co-authored papers 9
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers 8
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 8
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 7
Jack F Shern
Co-authored papers 6
Jill P Ginsberg
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Charles Keller
Children's Cancer Therapy Development Institute
Co-authored papers 5
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 5
Young K Song
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 3
Jun S Wei
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Ranadip Pal
Texas Tech University
Co-authored papers 3
Joel E Michalek
University of Texas Health Science Center
Co-authored papers 3
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Julie C Fitzgerald
Children's Hospital of Philadelphia
Co-authored papers 2
Joseph G Pressey
Co-authored papers 2
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Co-authored papers 2
Koichi Nishijo
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 2
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers 2
Zied Abdullaev
Co-authored papers 2
Release 1.2